Capricor Therapeutics
CAPR
18 hedge funds and large institutions have $1.88M invested in Capricor Therapeutics in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
62% more capital inflows, than outflows
Capital inflows: $748K | Capital outflows: $463K
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
20% more funds holding
Funds holding: 15 → 18 (+3)
0.44% more ownership
Funds ownership: 3.33% → 3.77% (+0.44%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock Fund Advisors
San Francisco,
California
|
+$67.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$62.5K |
| 3 |
Morgan Stanley
New York
|
+$57.7K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.2K |
| 5 |
Walleye Trading
New York
|
+$12.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$258K |
| 2 |
Goldman Sachs
New York
|
-$99.2K |
| 3 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$54K |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$41K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11K |
CAPR Hedge Fund Activity: Q4 2015 in Review
18 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q4 2015, worth a combined $1.88M — down 14% from $2.19M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CAPR positions and 4 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $67.5K. The largest seller was Sabby Management, cutting an estimated $258K.
- 18 institutional investors held Capricor Therapeutics (CAPR) as of Q4 2015, up from 15 in Q3 2015.
- Funds reported $1.88M of Capricor Therapeutics stock for Q4 2015, down 14% quarter-over-quarter.
- 7 funds opened new Capricor Therapeutics positions in Q4 2015 and 4 closed out, a net change of +3 holders.
- The largest Capricor Therapeutics buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $67.5K added.
- The largest Capricor Therapeutics seller in Q4 2015 was Sabby Management, an estimated $258K sold.
Based on aggregated 13F filings for Q4 2015.